the aid library

Filter

9388

Lessons from the Baltic Alcohol Control Policy Project: policies that contribute to decreasing burden of mortality and disease

World Health Organisation (WHO) World Health Organization (WHO) (2023) C_WHO

This short brief describes the main findings and the key lessons learned from the research project "Evaluation of the impact of alcohol control policies on morbidity and mortality in Lithuania and other Baltic states", funded by the United States National ... more

Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021

World Health Organization WHO (2021) C_WHO

Countries across the world are facing diverse epidemiological situations with varying response capacities and access to life saving tools. The World Health Organization (WHO) recommends that national ... more

WHO policy brief: Clinical management of COVID-19, 14 September 2022

World Health Organization WHO (2022) C_WHO

The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change an ... more

Rwanda: Non COMMUNICABLE DISEASES Policy

Ministry of Health, Rwanda (2015) C2

This document outlines Rwanda's policy on non-communicable diseases. The overall goal of NCDs Policy is to alleviate the burden of NCDs and their risk factors and protect Rwandan population from pre ... more

WHO Costing and Budgeting Tool for National Action Plans on Antimicrobial Resistance

World Health Organisation (WHO) (2021) C_WHO

In 2015, to advance the global and national response to antimicrobial resistance (AMR), the World Health Assembly issued resolution WHA68.7 calling for all Member States to develop AMR ... more

Guide to introducing human rabies vaccine into national immunization programmes

World Health Organization World Health Organization WHO (2022) C_WHO

Overview The aim of this guide is to support national immunization programme managers and others responsible for implementing human rabies vaccine programmes to: inform policy discussions and o ... more

6 steps for sustainable implementation of national action plans on antimicrobial resistance

World Health Organisation (WHO) (2021) C_WHO

The aim of this course is to provide information on the “WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human health sector” and the 6 steps ... more

Development of WHO immunization policy and strategic guidance

World Health Organization WHO (2024) C_WHO

This guidance describes the methods and processes of the Strategic Advisory Group of Experts (SAGE) on Immunization in developing evidence-based recommendations, WHO vaccine position papers, and other immunization policy guidance. Its aim is to faci ... more

Kenya National Nutrition Action Plan 2018-2022

Republic of Kenya, Ministry of Health (2018) CC

The KNAP 2018 - 2022 is the second National Nutrition Action Plan that operationalizes the National Food and Nutrition Security Policy 2012 and its ... more

UN-Water GLAAS TrackFin Initiative: tracking financing to sanitation, hygiene and drinking-water at national level

World Health Organization (WHO) (2017) C_WHO

This guidance document sets out a methodology to identify and track financing to the WASH sector in a coherent and consistent manner across several countries. It is designed to help countries track financing to the WASH sector on a regular and comparable basis and analyse this information to support ... more

Cervical Cancer Prevention and Control Policy (South Africa)

Dept. of Health, Republic of South Africa (2021) C1

Cervical cancer, along with maternal deaths, has been identified as a national priority in South Africa as well as other Sub-Saharan African countries. Cervical cancer is the second most common cancer among women in South Africa, after breast canc ... more

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended

World Health Organization WHO (2022) C_WHO

Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi ... more

Tracking urban health policies

World Health Organisation (WHO) (2023) C_WHO

To enhance health co-benefits across urban policies which tackle air pollution and climate change, WHO, in cooperation with various international, national, and local partners, implemented the Urban ... more

WHO interim guidance note: health workforce response to the COVID-19 pandemic: April 2020

World Health Organization WHO (2020) C_WHO

This guidance note identifies strategic action for policy-makers and managers at the national, subnational and facility level to address these different challenges.

Conditioned Domestic “Co-financing” Policies in Global Health

Sparkes S., Yungrattanachai M., Fan V., et al. Center for Global Development (2024) CC

Conditioned domestic financing policy, referring to the domestic financing of health projects, programs, and national responses conditioned by glob ... more

Strengthening and adjusting public health measures throughout the COVID-19 transition phases

World Health Organization (Europe) (2020) C_WHO

24 April 2020 Policy considerations for the WHO European Region This document provides key considerations for Member States to help them to decide on the modulation of large-scale restrictive public ... more

How can the township health system be strengthened in Myanmar?

Phone Myint; Than Tun Sein; Cassels, Andrew World Health Organization (WHO) (2015) C_WHO

Policy Note #3: Myanmar Health Systems in Transition Policy Notes Series
A network of basic health ... more

Liberia: Demographic and Health Survey 2019-2020

Liberia Institute of Statistics and Geo-Information Services (LISGIS) Monrovia, Liberia The DHS Program ICF (2021) C2

The LDHS provides an opportunity to inform policy and provide data for planning, implementation, and monitoring and evaluation of national health p ... more

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented ... policy interventions to reduce antimicrobial overuse. A systematic evidence map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Framework for audit of medical certification of cause of death at health facility

World Health Organization WHO (2022) C_WHO

Reliable cause specic mortality statistics are the cornerstone of national health information systems. They are essential for evidence-based decision making for monitoring ... more